orgalutran 0.25mg\0.5ml syringe solution for injection
organon - ganirelix acetate - solution for injection - 0.25 mg
orgalutran 0.25mg\0.5ml syringe injection*
merck sharp & dohme limited, united kingdom - ganirelix acetate - injection* - 0.25 mg
orilissa150 mg
abbvie biopharmaceuticals ltd, israel - elagolix as sodium - film coated tablets - elagolix as sodium 150 mg - elagolix - orilissa is indicated for the management of moderate to severe pain associated with endometriosis.
orilissa 200 mg
abbvie biopharmaceuticals ltd, israel - elagolix as sodium - film coated tablets - elagolix as sodium 200 mg - elagolix - orilissa is indicated for the management of moderate to severe pain associated with endometriosis.
ceziboe 0.25 mg inj. sol. s.c. pre-filled syr.
sun pharmaceutical industries europe b.v. - cetrorelix acetate - eq. cetrorelix 0,25 mg/ml - solution for injection in pre-filled syringe - 0,25 mg - cetrorelix acetate - cetrorelix
fyremadel 0.25 mg/0.5 ml inj. sol. s.c. pre-filled syr.
sun pharmaceutical industries europe b.v. - ganirelix acetate 0,54 mg/ml - eq. ganirelix 0,5 mg/ml - solution for injection in pre-filled syringe - 0,25 mg/0,5 ml - ganirelix acetate 0.54 mg/ml - ganirelix
cetrotide powder lyophilized for solution for s/c injection
baxter oncology gmbh - cetrorelix (cetrorelix acetate) - powder lyophilized for solution for s/c injection - 0,25mg
ryeqo
gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyoma - pituitary and hypothalamic hormones and analogues - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
cetrotide 0.25mg inj 0.25 mg
شركة مستودع الادوية العربي - the arab drug store p.s.c - cetrorelix 0.25 mg - 0.25 mg
cetrotide 0.25mg inj 0.25 mg
شركة مستودع الادوية العربي - the arab drug store p.s.c - cetrorelix 0.25 mg - 0.25 mg